Company profile: Recombia
1.1 - Company Overview
Company description
- Provider of synthetic biology and genome engineering solutions, offering yeast strain optimization, metabolic engineering, and microbial strain engineering to enhance industrial fermentation, produce natural products, and support various industrial applications using rationally designed genetic modifications with high precision, efficiency, and throughput.
Products and services
- Strain Engineering: Engineers and modifies microbial strains for industrial applications via high-throughput, rationally-designed genome edits delivering unprecedented precision and efficiency
- Metabolic Engineering: Introduces and optimizes metabolic pathways in microorganisms to produce natural products using precision-engineered, rationally-designed genetic modifications with unprecedented throughput and efficiency
- Yeast Strain Optimization: Enhances yeast strains through genome editing to improve industrial fermentation processes using genome-edited, rationally-designed modifications delivering unprecedented precision, efficiency, and throughput.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Recombia
Gemini Bio
HQ: United States
Website
- Description: Provider of FDA-registered biological products and chemical reagents for the global cell culture community, offering cell culture sera (fetal bovine and other human/animal), custom and specialized media and buffers, supplements and reagents (amino acids, antibiotics, antimycotics), high purity water including WFI-quality, and cGMP contract manufacturing/private-label process liquids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gemini Bio company profile →
Altucell
HQ: United States
Website
- Description: Provider of cell, molecular, and regenerative therapy for treating diabetes, addressing an unmet need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altucell company profile →
DiaSys Diagnostics
HQ: Germany
Website
- Description: Provider of diagnostic system solutions, offering over 90 liquid-stable, ready-to-use reagents for clinical chemistry and immunoturbidimetric diagnostics (routine and special), including Procalcitonin FS, LDH 21 FS, LDL-c direct FS, and Total bile acids 21 FS, as well as automated and semi-automated clinical chemistry analyzers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiaSys Diagnostics company profile →
Pfeiffer Vacuum
HQ: Germany
Website
- Description: Provider of vacuum solutions, offering hybrid and magnetically levitated turbopumps; vacuum and backing pumps (rotary vane, Roots, turbomolecular); precise vacuum gauges (Pirani, Bayard-Alpert); PrismaPro mass spectrometers; helium/air leak detectors; valves, flanges, customized vacuum chambers; and integrated vacuum systems for semiconductor contamination management and die casting (Vacu2).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pfeiffer Vacuum company profile →
Synpromics
HQ: United Kingdom
Website
- Description: Provider of synthetic promoters to control gene expressions and regulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synpromics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Recombia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Recombia
2.2 - Growth funds investing in similar companies to Recombia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Recombia
4.2 - Public trading comparable groups for Recombia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →